AACR logo

Advertisement

More articles from Research Watch

Gut Microbiota Drive Androgen Resistance in Prostate Cancer
Cancer Discovery Oct 2021, DOI: 10.1158/2159-8290.CD-RW2021-153
Sub–Tumor Microenvironments Influence PDAC Progression and Therapy Response
Cancer Discovery Oct 2021, DOI: 10.1158/2159-8290.CD-RW2021-151
MRgFUS-Mediated Antibody Delivery Improves Drug Uptake across the BBB
Cancer Discovery Oct 2021, DOI: 10.1158/2159-8290.CD-RW2021-149
Mutant Clones in Adjacent Normal Epithelium Limit Early Tumorigenesis
Cancer Discovery Oct 2021, DOI: 10.1158/2159-8290.CD-RW2021-152
Dual CD19/CD22 CAR T Cells Show Feasibility in Pediatric/Young Adult B-ALL
Cancer Discovery Oct 2021, DOI: 10.1158/2159-8290.CD-RW2021-150
Microbiota-Induced IFN-I Signaling Promotes an Antitumor Microenvironment
Cancer Discovery Oct 2021, DOI: 10.1158/2159-8290.CD-RW2021-145
Epigenetic Heterogeneity Controls Glioma Cell State and Stress Response
Cancer Discovery Oct 2021, DOI: 10.1158/2159-8290.CD-RW2021-147
Inhibiting BTK and IDO Enhances Dendritic Cell–Mediated Immune Response
Cancer Discovery Oct 2021, DOI: 10.1158/2159-8290.CD-RW2021-148
Engineered Bacteria Increase L-Arginine to Improve Immunotherapy Response
Cancer Discovery Oct 2021, DOI: 10.1158/2159-8290.CD-RW2021-146
Cop1 Controls Macrophage Infiltration and Antitumor Immunity in TNBC
Cancer Discovery Oct 2021, DOI: 10.1158/2159-8290.CD-RW2021-144

Pages